Angelika Joos is a licensed pharmacist. Since 2001, she is responsible for regulatory policy issues at Merck Sharp & Dohme's Regulatory Affairs department in Brussels. Over the past 17 years, Angelika has gained strategic as well as operational experience with all regulatory procedures and various products in different therapeutic areas.
In her current position as Head Regulatory Policy EU & Most of World she is responsible for monitoring and implementing regulatory policies and procedures and advising the company on regulatory strategies. She represents MSD in the EFPIA Scientific Regulatory and Manufacturing Policy Committee and in the IFPMA Regulatory Policy Committee. Her main interests are related to clinical trials, pharmacovigilance, HTA and paediatrics.
She has been a member of the DIA Advisory Council Europe since 2008 and has been involved in the organisation of several DIA Forums as well as two DIA EuroMeetings.
Dr Marcus Müllner
Dr Müllner is Head of the Austrian Medicines and Medical Devices Agency, a position he has held since 2006. He has also worked for the European Medicines Agency, the Cochrane Anaesthesia Review Group, where he was Statistical Editor, and the ethics committee of the Wiener Krankenanstaltenverbund, Vienna. In addition, he was Associate Editor and Editorial Registrar on the British Medical Journal.
Dr Müllner graduated as a Medical Doctor from the Medical University of Vienna in 1992, where he trained and worked as a specialist in internal medicine and clinical epidemiologist at the Medical University of Vienna. He also has a sub-speciality in intensive care and an MSc in epidemiology from the University College of London / London School of Hygiene and Tropical Medicine and a diploma for principal investigators’ training from the Austrian Medical Association.